Avinger (NASDAQ:AVGR) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Avinger (NASDAQ:AVGR) in a research note released on Thursday morning. The brokerage issued a hold rating on the medical device company’s stock.

Avinger Price Performance

AVGR opened at $0.47 on Thursday. Avinger has a 12-month low of $0.36 and a 12-month high of $4.37. The business has a 50 day moving average of $0.49 and a 200-day moving average of $0.71. The stock has a market cap of $1.57 million, a price-to-earnings ratio of -0.04 and a beta of 1.09.

About Avinger

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.